Feb 16
CLC bio partners with Pacific Biosciences
Today Pacific Biosciences announced the initial members of their partner program, and CLC bio is included as the only high-throughput sequencing data analysis software provider.
We have thought carefully about what it takes to successfully introduce a new generation of technology to the marketplace, and putting in place an entire ecosystem of complementary solutions has been one of our strategies from the beginning, states Hugh Martin, Chairman and Chief Executive Officer of Pacific Biosciences.
From CLC bio’s start 5 years ago, it has been a core strategy for us to be an independent, cross-platform software provider, whether it relates to operating systems or high-throughput sequencing instruments. We’re currently supporting all the second generation sequencing instruments from Illumina, Applied Biosystems, Roche 454, as well as Helicos. We’re continuing that strategy with the 3rd generation sequencers starting to come out this year.